CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–#beigene–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced that the Company will participate in the Guggenheim Healthcare Talks, 2022 Oncology Conference on Thursday, February 10, 2022 at 9:00 a.m. ET.
A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of approximately 8,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com.
Contacts
Investor
Kevin Mannix
+1 857-302-5189
ir@beigene.com
Media
Liza Heapes
+1 857-302-5663
media@beigene.com
Key takeaways:GitHub Copilot now supports server-to-server authentication for automated enterprise server workflows.Sweden's government blocked access…
Key takeaways:Dearness allowance is a cost-of-living component associated with Indian government salaries and pensions, usually…
Key takeaways:Najmul Hossain Shanto is the captain of Bangladesh's Test cricket team leading them in…
Key takeaways:Astrological readings for late October 2026 forecast career success and a new direction for…
Key takeaways:Mominul Haque was dismissed as Bangladesh reached 96-2 at lunch on Day 1 of…
Key takeaways:EAAA India Alternatives IPO GMP was reported flat on Day 3, with the issue…